Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antibody Responses 8 Months after Asymptomatic or Mild SARS-CoV-2 Infection.

Literature DB >> 33350923

Antibody Responses 8 Months after Asymptomatic or Mild SARS-CoV-2 Infection.

Pyoeng Gyun Choe, Kye-Hyung Kim, Chang Kyung Kang, Hyeon Jeong Suh, EunKyo Kang, Sun Young Lee, Nam Joong Kim, Jongyoun Yi, Wan Beom Park, Myoung-Don Oh.

Abstract

Waning humoral immunity in coronavirus disease patients has raised concern over usefulness of serologic testing. We investigated antibody responses of 58 persons 8 months after asymptomatic or mildly symptomatic infection with severe acute respiratory syndrome coronavirus 2. For 3 of 4 immunoassays used, seropositivity rates were high (69.0%-91.4%).

Entities: Chemical

Keywords: 2019 novel coronavirus disease; COVID-19; ECLIA; ELISA; SARS-CoV-2; antibody; coronavirus disease; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses

Mesh：

Substances：
Antibodies, Viral

Year: 2020 PMID： 33350923 PMCID： PMC7920668 DOI： 10.3201/eid2703.204543

Source DB: PubMed Journal: Emerg Infect Dis ISSN： 1080-6040 Impact factor: 16.126

13 in total

1. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.

Authors: Quan-Xin Long; Xiao-Jun Tang; Qiu-Lin Shi; Qin Li; Hai-Jun Deng; Jun Yuan; Jie-Li Hu; Wei Xu; Yong Zhang; Fa-Jin Lv; Kun Su; Fan Zhang; Jiang Gong; Bo Wu; Xia-Mao Liu; Jin-Jing Li; Jing-Fu Qiu; Juan Chen; Ai-Long Huang
Journal: Nat Med Date: 2020-06-18 Impact factor: 53.440

2. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction.

Authors: Chee Wah Tan; Wan Ni Chia; Xijian Qin; Pei Liu; Mark I-C Chen; Charles Tiu; Zhiliang Hu; Vivian Chih-Wei Chen; Barnaby E Young; Wan Rong Sia; Yee-Joo Tan; Randy Foo; Yongxiang Yi; David C Lye; Danielle E Anderson; Lin-Fa Wang
Journal: Nat Biotechnol Date: 2020-07-23 Impact factor: 54.908

3. Correlation between viral RNA shedding and serum antibodies in individuals with coronavirus disease 2019.

Authors: C C Jin; L Zhu; C Gao; S Zhang
Journal: Clin Microbiol Infect Date: 2020-05-23 Impact factor: 8.067

4. Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis.

Authors: Mayara Lisboa Bastos; Gamuchirai Tavaziva; Syed Kunal Abidi; Jonathon R Campbell; Louis-Patrick Haraoui; James C Johnston; Zhiyi Lan; Stephanie Law; Emily MacLean; Anete Trajman; Dick Menzies; Andrea Benedetti; Faiz Ahmad Khan
Journal: BMJ Date: 2020-07-01

5. Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19).

Authors: Kaijin Xu; Yanfei Chen; Jing Yuan; Ping Yi; Cheng Ding; Wenrui Wu; Yongtao Li; Qin Ni; Rongrong Zou; Xiaohe Li; Min Xu; Ying Zhang; Hong Zhao; Xuan Zhang; Liang Yu; Junwei Su; Guanjing Lang; Jun Liu; Xiaoxin Wu; Yongzheng Guo; Jingjing Tao; Ding Shi; Ling Yu; Qing Cao; Bing Ruan; Lei Liu; Zhaoqin Wang; Yan Xu; Yingxia Liu; Jifang Sheng; Lanjuan Li
Journal: Clin Infect Dis Date: 2020-07-28 Impact factor: 9.079

6. Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients.

Authors: Pyoeng Gyun Choe; Chang Kyung Kang; Hyeon Jeong Suh; Jongtak Jung; EunKyo Kang; Sun Young Lee; Kyoung-Ho Song; Hong Bin Kim; Nam Joong Kim; Wan Beom Park; Eu Suk Kim; Myoung-Don Oh
Journal: Emerg Infect Dis Date: 2020-06-24 Impact factor: 6.883

7. Selecting coronavirus disease 2019 patients with negligible risk of progression: early experience from non-hospital isolation facility in Korea.

Authors: Pyoeng Gyun Choe; Eun Kyo Kang; Sun Young Lee; Boram Oh; Dahae Im; Hyo Yeon Lee; Hyemin Jung; Chang Kyung Kang; Min Sun Kim; Wan Beom Park; Eun Hwa Choi; BeLong Cho; Myoung-Don Oh; Nam Joong Kim
Journal: Korean J Intern Med Date: 2020-05-29 Impact factor: 2.884

8. Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison.

Authors:
Journal: Lancet Infect Dis Date: 2020-09-23 Impact factor: 25.071

9. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months.

Authors: Ania Wajnberg; Fatima Amanat; Adolfo Firpo; Deena R Altman; Mark J Bailey; Mayce Mansour; Meagan McMahon; Philip Meade; Damodara Rao Mendu; Kimberly Muellers; Daniel Stadlbauer; Kimberly Stone; Shirin Strohmeier; Viviana Simon; Judith Aberg; David L Reich; Florian Krammer; Carlos Cordon-Cardo
Journal: Science Date: 2020-10-28 Impact factor: 47.728

41 in total

1. The protective effect of previous COVID-19 infection in a high-prevalence hospital setting.

Authors: Favian Narrainen; Madeleine Shakeshaft; Hibo Asad; Abigail Holborow; Ian Blyth; Brendan Healy
Journal: Clin Med (Lond) Date: 2021-09 Impact factor: 5.410

2. Effect of Immunosuppressive Diseases and Rituximab Infusions on Allowing COVID-19 Infection to Relapse.

Authors: Rohan M Prasad; Shaurya Srivastava; Enhua Wang; Jason Z Liu; Rakesh Gami; Ayat Abdelgadir; Akhil Sharma; Sumugdha Rayamajhi; Richa Tikaria
Journal: Perm J Date: 2021-10-29

Review 3. Variation in the Humoral Immune Response Induced by the Administration of the BNT162b2 Pfizer/BioNTech Vaccine: A Systematic Review.

Authors: Karen Cortés-Sarabia; Mayralina Gutiérrez-Torres; Escarlet Maleny Mendoza-Renteria; Marco Antonio Leyva-Vázquez; Amalia Vences-Velázquez; Daniel Hernández-Sotelo; Fredy Omar Beltrán-Anaya; Oscar Del Moral-Hernández; Berenice Illades-Aguiar
Journal: Vaccines (Basel) Date: 2022-06-07

4. Molecular and Serologic Diagnostic Technologies for SARS-CoV-2.

Authors: Halie M Rando; Christian Brueffer; Ronan Lordan; Anna Ada Dattoli; David Manheim; Jesse G Meyer; Ariel I Mundo; Dimitri Perrin; David Mai; Nils Wellhausen; Covid-Review Consortium; Anthony Gitter; Casey S Greene
Journal: ArXiv Date: 2022-04-26

5. SARS-CoV-2 Infection Detection by PCR and Serologic Testing in Clinical Practice.

Authors: Douglas Murad; Sukantha Chandrasekaran; Ajaya Pillai; Omai B Garner; Christopher T Denny
Journal: J Clin Microbiol Date: 2021-06-18 Impact factor: 5.948

6. Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 2020¹.

Authors: Kirsten E Wiens; Pinyi Nyimol Mawien; John Rumunu; Damien Slater; Forrest K Jones; Serina Moheed; Andrea Caflisch; Bior K Bior; Iboyi Amanya Jacob; Richard Lino Lako; Argata Guracha Guyo; Olushayo Oluseun Olu; Sylvester Maleghemi; Andrew Baguma; Juma John Hassen; Sheila K Baya; Lul Deng; Justin Lessler; Maya N Demby; Vanessa Sanchez; Rachel Mills; Clare Fraser; Richelle C Charles; Jason B Harris; Andrew S Azman; Joseph F Wamala
Journal: Emerg Infect Dis Date: 2021-06 Impact factor: 6.883

7. Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys.

Authors: Hassan Alkharaan; Shaghayegh Bayati; Cecilia Hellström; Soo Aleman; Annika Olsson; Karin Lindahl; Gordana Bogdanovic; Katie Healy; Georgios Tsilingaridis; Patricia De Palma; Sophia Hober; Anna Månberg; Peter Nilsson; Elisa Pin; Margaret Sällberg Chen
Journal: J Infect Dis Date: 2021-08-02 Impact factor: 7.759